This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Etherna Immunitherapies Nv, Vrije Universiteit Brussel. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 194 
Years Active: 2026
Title: Raymond Michel Schiffelers and Lipid Nanoparticle Innovation.
Introduction
Raymond Michel Schiffelers is an inventor associated with Yalelaan, the Netherlands. His work includes lipid nanoparticle technology designed to deliver nucleic acids, particularly messenger RNA (mRNA).
Latest Patents
Schiffelers is associated with 1 patent, titled “Lipid nanoparticles comprising sterols and mRNA.” The invention concerns lipid nanoparticles containing an ionizable lipid, a phospholipid, a sterol, a PEG lipid, and one or more nucleic acids. It describes formulations with less than about 1 mol% of a C14-PEG2000 lipid, alongside specified proportions of other lipids.
The patent describes using these nanoparticles to deliver nucleic acid molecules for immunogenic purposes, especially mRNA. Potential applications include vaccines for cancer and infectious diseases. It also provides methods for preparing the lipid nanoparticles.
Career Highlights
The organizations listed in connection with Schiffelers’s career include Vrije Universiteit Brussel and Etherna Immunotherapies NV.
Collaborations
His listed coworkers include Sanne Bevers and Sander Alexander Antonius Kooijmans. Their names are associated with the collaborative research and development context surrounding his work.
Conclusion
Raymond Michel Schiffelers’s patent focuses on lipid nanoparticle formulations for mRNA delivery, with potential applications in vaccines targeting cancer and infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile